It’s easy to be distracted by volatility and the cacophony of...

It’s easy to be distracted by volatility and the cacophony of noise created by certain posters. I prefer these opportunities to focus on sector fundamental like you’ve just posted. While the delisting may not result in immediate gratification I’m certainly in your camp of belief that it will be a strategically sound decision once the company starts releasing the psi-GAD, IHL-675A and OSA results.

There is interest building again in psychedelics in the US and overall the depth of knowledge and capital will lift the stock towards its peer valuations, which are now at least 3 to 4 times where IXHL is valued. Incannex has a far better story to tell than Cybin too.